As part of the study, a screening was performed in C. elegans using Nagi Bioscience’s fully automated high-content screening platform in order to determine the efficacy and necessary dosage of the test compounds.
We are proud to announce that Nagi Bioscience has entered the distinguished TOP 100 Swiss Start Up 2022 ranking under the biotech category.
Nagi & MolGen in tandem at the European Worm Meeting 2022 at booth #5
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
Meet the Organism-on-Chip that is revolutionizing the biotech sector in Nagi’s booth at Future Labs Live in Basel.
Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.
We are delighted to announce our participation once again in the Swiss Biotech Day.
Meet us at Longevity Leaders World Congress and learn more about our pioneer Organism-on-Chip technology
Our CSO and co-founder Laurent Mouchiroud will present Nagi’s pioneer technology used in a successful project for Bayer CropScience at the prestigious SOT Annual Meeting.
Meet the first Organism-on-Chip technology on Friday 25th March at 14:30 CET at the TechTour Future22 event.